0001140361-16-059857.txt : 20160401
0001140361-16-059857.hdr.sgml : 20160401
20160401171513
ACCESSION NUMBER: 0001140361-16-059857
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160401
DATE AS OF CHANGE: 20160401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AFFYMETRIX INC
CENTRAL INDEX KEY: 0000913077
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 770319159
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3420 CENTRAL EXPRESSWAY
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
BUSINESS PHONE: 4087315000
MAIL ADDRESS:
STREET 1: 3420 CENTRAL EXPRESSWAY
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NACHTSHEIM JAMI K
CENTRAL INDEX KEY: 0001223017
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28218
FILM NUMBER: 161548129
4
1
doc1.xml
FORM 4
X0306
4
2016-03-31
0
0000913077
AFFYMETRIX INC
AFFX
0001223017
NACHTSHEIM JAMI K
C/O AFFYMETRIX, INC.
3420 CENTRAL EXPRESSWAY
SANTA CLARA
CA
95051
1
0
0
0
Common Stock
2016-03-31
4
D
0
35662
D
0
D
Stock Option (right to buy)
7.85
2016-03-31
4
D
0
20000
D
Common Stock
20000
0
D
Stock Option (right to buy)
5.88
2016-03-31
4
D
0
10000
D
Common Stock
10000
0
D
Stock Option (right to buy)
5.07
2016-03-31
4
D
0
10000
D
Common Stock
10000
0
D
Stock Option (right to buy)
3.68
2016-03-31
4
D
0
10000
D
Common Stock
10000
0
D
Stock Option (right to buy)
8.23
2016-03-31
4
D
0
20000
D
Common Stock
20000
0
D
Stock Option (right to buy)
12.37
2016-03-31
4
D
0
5053
D
Common Stock
5053
0
D
Pursuant to the Agreement and Plan of Merger dated as of January 8, 2016 by and among Affymetrix, Inc. ("Affymetrix"), Thermo Fisher Scientific Inc. ("Thermo Fisher") and White Birch Merger Co. (the "Merger Agreement"), (x) each outstanding share of common stock of Affymetrix was cancelled and converted into the right to receive $14.00 in cash; (y) each vested stock option was cancelled and converted into the right to receive a cash payment per share equal to the excess, if any, of $14.00 over the exercise price; and (z) each unvested stock option and RSU, whether vested or unvested, was assumed by Thermo Fisher and converted into the right to receive a cash payment per share equal to the excess, if any, of $14.00 over the exercise price, as applicable.
/s/ Siang H. Chin, Attorney-in-Fact for Jami Nachtsheim
2016-04-01